The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
I think that the Kissei deal was actually fairly well progressed some 2 years ago, so it was not pure hyperbole to say it could arrive 'soon'.
I don't see how any substantive talks on 004 could really begin until more test results come in & our patent position is secure. Also we need to appreciate we don't know what the competitive position is regarding Lynparza substitutes AZ, Merck & others have in the pipeline. Presumably they have been trying to create value added follow-up drugs that can be patented prior to the Lynparza patent expiry.
Was half expecting a NXP001 update today.
Fair point filter.
Guess it just gave me flashbacks to two years ago with constant posting by offshoresailor saying the same thing.
'Mars, to say ‘Thing is deals can drop any time’ is blatantly untrue. Deals take time and effort, they don’t fall out of thin air.'
Have to say you can't say blatantly untrue, how do you know the time and effort hasn't already been put in?
Soup I did say they are not instant and we were not in the right time zone what I meant was they will happen without warning
Why are there virtually no listed companies without a Chairman & at least one executive director (if you can find them please give details)? Because they are essential leadership positions in any company and to not have them says to the world you are not a serious company. New investors - who we desperately need - are not going to touch a company that is such a shambles it cant even organise a new Chairman & appoint an executive director.
To finance the testing programme for 002 & 004 we need way higher revenue from the Lanstead scheme - a higher share price is actually priority number 1, and we get there by by being as 'investor friendly' as possible. We are literally leaderless, after each previous resignation we got a replacement same day or at least a plan. The next crucial step was an interview where the new Chairman/ executive tried to calm investor nerves & set out the future that they would 'lead' us to. Now in week 5 - nothing, because we literally dont have anyone in the key 'leadership' positions.
Mars, to say ‘Thing is deals can drop any time’ is blatantly untrue.
Deals take time and effort, they don’t fall out of thin air.
Mgt structure has to be necessary for the job, any counterparty will not rate an over resourced structure. As far as the sp goes mgt structure has no impact, it is the sellers who drive the sp. Last two comms were good not just with info but there is a plan and a schedule. Thing is deals can drop any time they are not instant when it happens it’s not pennies so atm we are not in the closing zone in terms of timescale since DGs appointment. What is interesting despite AZ/Merck partnership with Lynparza this is irrelevant with 004 unless their agreement extends to new/ unresearched versions ..unlikely.
Adding members to board would lead to a limited and short lived recovery imo (still needed tho). The thing that would put off most retail nvestors is the sp performance over time. To end that we need incoming revenue announced. Institutional investors do not generally get interested in micro caps like this. We need retail investors to be convinced again, I believe we're some way off that.
Not wanting buyers with a 33% spread.
Management structure needs addressing asap, too risky for proper investors they wouldn't touch us as we are.
It's obvious as the last 2 decent updates have done nothing, recruitment needed even if it's just 1
I dont think we have to end the company but I do think we end the nonsense that a listed company can muddle along without a Chairman & 1 executive director. What new investor is going to invest in a company without these essential positions filled - as they have been for NFX every single time one has become vacant. The 002 & 004 updates were sensible & positive but could do nothing to get the share price back to where we were a month ago, let alone higher.
Thanks Soup.
Its difficult to say Taz, as a starting point we can see regular retail traders buys and sells as O trades, then cross these off looking at the history. e.g the 390,218 sell at 14:53 today matches a 390,218 buy yesterday at 16:23.
There are quite a number of trades today that can be paired off with buys over the past two days.
On the A trades, its a bit more difficult to figure out whats going on.
Overall since A trades first started appearing on NFX deals around the beginning of Feb this year there have been 71.2m shares go through as A trades.
These appear separate to MM quotes, so you will see someone on the BID (trying to buy stock) which they then raise until someone is willing to sell it to them. This happened earlier today, at open there was 950k on the bid at 0.33p which was below the MM's 0.35p.
Over time they raised this till their buy was filled at 0.355p
Soup, can see A trades still and majorities are biggish sells. Who are they? I can only think of lanstead.
Mostly traders who bought yesterday or day before selling up.
Will only go down there's no need to be surprised, this dog will only move a fraction on some kind of meaningful company structure to drive progress and then updates, until then it has scope IMO to hit say 0.10, then it really is at notional and an easy bagger if someone RTOs it or something (forget all IP at that stage, potentially even now, it's worthless)
Looks like lanstead is selling more. We had 2 good updates yet we are heading for another 52 week low.
You just back from a world voyage goup:-) ?
ps. welcome back goup. Not seen you for a few months.
Let's end this ,take what's on the table and move on